Mark J. Pettenati

8.1k citations
148 papers · 5.1k · 1 hit paper · h-index 36

Impact in

  • Hematology top 0.2%
    • Acute Myeloid Leukemia Research
    • Chronic Myeloid Leukemia Treatments
    • Hematopoietic Stem Cell Transplantation
  • Genetics top 1%
    • Genomic variations and chromosomal abnormalities
    • Myeloproliferative Neoplasms: Diagnosis and Treatment

Papers in

    • Retinoids in leukemia and cellular processes 9
    • Acute Myeloid Leukemia Research 43
    • Chronic Myeloid Leukemia Treatments 19

Mark J. Pettenati

145 papers receiving 4.9k citations

Mark J. Pettenati's Hit Papers

Frequency of prolonged remission duration after high-dose cytarabine intensification in acute myeloid leukemia varies by cytogenetic subtype. 1998 · 508 citations
5080+9+18Years since publication100200300400500

Peers

Mark J. Pettenati
Comparison fields: 5 of 135
  • Hematology 2.3k
  • Genetics 620
  • Public Health, Environmental and Occupational Health 1.1k
  • Genetics 998
  • Molecular Biology 2.1k
Replace Bertil Johansson with:
Bertil Johansson Sweden
Athena M. Cherry United States
Jan Cools Belgium
Anna Savoia Italy
Tracy Chaplin United Kingdom
Lidia Larizza Italy
Tobias Gedde‐Dahl Norway
Arleen D. Auerbach United States
Jean Michel Foidart Belgium
Akiko Shimamura United States
Mark J. Pettenati relative to Bertil Johansson Sweden Bertil Johansson's profile →
Citations per field
00.5×1.5×
Bertil Johansson · 1×
Citations per year

Countries citing papers authored by Mark J. Pettenati

Since Specialization
Citations

This map shows the geographic impact of Mark J. Pettenati's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark J. Pettenati with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark J. Pettenati more than expected).

Fields of papers citing papers by Mark J. Pettenati

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark J. Pettenati. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark J. Pettenati. The network helps show where Mark J. Pettenati may publish in the future.

Co-authors

The 25 scholars most cited alongside Mark J. Pettenati, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Mark J. Pettenati Line = papers co-authored together Mark J. Pettenati links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 148 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Frequency of prolonged remission duration after high-dose cytarabine intensification in acute myeloid leukemia varies by cytogenetic subtype.
Hit paper breakdown →
1998508
2 2005265
3 2006253
4 1986224
5 1999223
6 2004156
7 2006132
8 2001126
9 1987122
10 1999115
11 200499
12 200197
13 199593
14 199790
15 200189
16 198985
17 199582
18 200480
19 200179
20 199875

About Mark J. Pettenati

Mark J. Pettenati is a scholar working on Molecular Biology, Hematology, Genetics, Public Health, Environmental and Occupational Health and Pediatrics, Perinatology and Child Health, having authored 148 papers that have together received 5.1k indexed citations. Recurring topics across this work include Acute Myeloid Leukemia Research (43 papers), Acute Lymphoblastic Leukemia research (19 papers), Chronic Myeloid Leukemia Treatments (19 papers), Prenatal Screening and Diagnostics (18 papers), Genomic variations and chromosomal abnormalities (17 papers), Chromosomal and Genetic Variations (12 papers), Sarcoma Diagnosis and Treatment (9 papers) and Retinoids in leukemia and cellular processes (9 papers). The work is most often cited by research in Hematology (2.3k citations), Genetics (620 citations), Public Health, Environmental and Occupational Health (1.1k citations), Genetics (998 citations) and Molecular Biology (2.1k citations). Mark J. Pettenati has collaborated with scholars based in United States, United Kingdom and Spain. Frequent co-authors include Andrew J. Carroll, Clara D. Bloomfield, Robert J. Mayer, P. Nagesh Rao, Richard A. Larson, Charles A. Schiffer, Krzysztof Mrózek, Ramana Tantravahi, Frederick R. Davey and Amy S. Ruppert. Their work appears in journals such as Genomics, Blood, Archives of Pathology & Laboratory Medicine, Journal of Clinical Oncology and Prenatal Diagnosis.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact